Feline Gastrointestinal Lymphoma: Welfare and Treatment

Key Facts

• Small cell (low-grade) lymphoma is the most common form in older cats and has an excellent prognosis with treatment
• Large cell (high-grade) lymphoma has a poor prognosis even with chemotherapy — median survival 2-4 months
• Clinical signs include chronic vomiting, diarrhea, weight loss, and reduced appetite — often progressive over months
• Low-grade lymphoma is treated with oral chlorambucil and prednisolone with median survival over 2 years
• Distinguishing low from high-grade lymphoma requires biopsy and immunohistochemistry — not just cytology

Welfare Considerations

Feline gastrointestinal lymphoma welfare is profoundly shaped by the distinction between low-grade and high-grade disease. Low-grade lymphoma treated with chlorambucil and prednisolone typically produces dramatic clinical improvement within 2-4 weeks — cats often return to near-normal weight, appetite, and quality of life. High-grade lymphoma carries a grave prognosis with limited treatment response, making palliative care and quality of life preservation the welfare priority. Distinguishing the two types through appropriate diagnostics is a critical welfare decision — the treatment approach, prognosis, and quality-of-life trajectory are fundamentally different.

What You Can Do

• Pursue definitive histopathological biopsy to distinguish low from high-grade lymphoma before making treatment decisions
• Commit to the chlorambucil and prednisolone protocol for low-grade lymphoma — responses are often excellent
• Use quality-of-life scoring at monthly veterinary visits to track treatment response objectively
• For high-grade lymphoma, prioritize palliative comfort care over aggressive chemotherapy given the limited prognosis
• Monitor cobalamin (B12) levels and supplement deficient cats — low B12 is common and correctable in GI lymphoma